Dalva-Aydemir, S. Et Al. 2013. Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin. 55th Annual Meeting of the American-Society-of-Hematology , (Louisiana, United States Of America).

Dalva-Aydemir, S., Adekola, K. U. A., Koblinski, J., Raje, N., Rosen, S. T., & Shanmugam, M., (2013). Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin . 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America

Dalva-Aydemir, SEVİM Et Al. "Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin," 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 2013

Dalva-Aydemir, SEVİM D. Et Al. "Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America, 2013

Dalva-Aydemir, S. Et Al. (2013) . "Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America.

@conferencepaper{conferencepaper, author={SEVİM DALVA AYDEMİR Et Al. }, title={Targeting Glycolysis and Compensatory Mitochondrial Metabolism In An In Vivo Xenograft Model Of Multiple Myeloma With FDA Approved Ritonavir and Metformin}, congress name={55th Annual Meeting of the American-Society-of-Hematology}, city={Louisiana}, country={United States Of America}, year={2013}}